News Sentiment

SRTA sentiment intelligence

Strata Critical Medical, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 5.11 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend active

-5.5% over one week, -5.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Strata Critical Medical Inc. (SRTA) Holds Near Key Support Amid Modest Pullback - Golden Cross

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -5.5% Price reacting lower
Trend fit Trend active -5.9% over four weeks
Fair value 3.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 33
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 8
Stock Titan 7
Market source 5
Seeking Alpha 4
simplywall.st 4
Sahm 3
TradingKey 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 15
Deals and strategy 8
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 51
TradingView Direct company coverage

Enterprise value to EBITDA forward of Strata Critical Medical, Inc. – NASDAQ:SRTA

This article provides financial information for Strata Critical Medical, Inc. (NASDAQ: SRTA), specifically focusing on its Enterprise Value to EBITDA forward metric. The content highlights the company's stock market presence on NASDAQ and confirms that market data is provided by

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 22:10
Source
TradingView
Seeking Alpha Direct company coverage

Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant Logistics

The article rates Strata Critical Medical (SRTA) as a "buy" due to its expanding market share, operational efficiencies, strategic acquisitions, and focus on NRP technology, which positions it for future growth and industry consolidation. In contrast, TransMedics (TMDX) receives

Tone
Positive 75/100
Event
Deals and strategy
Published
07 Jul 2026 12:10
Source
Seeking Alpha
TradingView Direct company coverage

Enterprise value to revenue forward of Strata Critical Medical, Inc. – NASDAQ:SRTA

The article concerns the enterprise value to revenue forward metric for Strata Critical Medical, Inc. (NASDAQ:SRTA). It mentions that the market was closed and no trades occurred, indicating potential focus on financial analysis rather than active trading. The content seems to be

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 05:11
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Strata Critical Medical, Inc. – NASDAQ:SRTA

This article provides financial information for Strata Critical Medical, Inc. (NASDAQ: SRTA), specifically focusing on its Enterprise Value to EBIT (Earnings Before Interest and Taxes) forward ratio. The content appears to be a financial data page from TradingView, displaying com

Tone
Neutral 50/100
Event
Earnings
Published
04 Jul 2026 09:09
Source
TradingView
TradingView Direct company coverage

Strata Critical Medical, Inc. Class A Actuals & Estimates (NASDAQ:SRTA)

This article provides an overview of Strata Critical Medical, Inc. (NASDAQ: SRTA) stock, including current prices, historical performance, analyst forecasts, and various financial metrics. It details the company's market capitalization, earnings, revenue, and EBITDA, while also o

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 05:41
Source
TradingView
TradingView Direct company coverage

SRTA Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Strata Critical Medical, Inc. (SRTA) stock, based on analyst opinions. It details the current stock price, historical performance, earnings reports, revenue, and other financial metrics for investors. The content also addresse

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 19:10
Source
TradingView
Sahm Direct company coverage

Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform

Strata Critical Medical, Inc. (Nasdaq: SRTA) announced the acquisition of Heart and Lung Transplant National Recovery Program (HLT-NRP) for $21.5 million. This acquisition significantly expands Strata's network of experienced transplant surgeons, adding clinical depth and geograp

Tone
Positive 73/100
Event
Deals and strategy
Published
25 Jun 2026 18:39
Source
Sahm
www.marketscreener.com Direct company coverage

Strata Critical Medical, Inc.(NasdaqCM:SRTA) added to S&P Health Care Services Select Industry Index

Strata Critical Medical, Inc. (NasdaqCM:SRTA) has been added to the S&P Health Care Services Select Industry Index. This news follows several recent events for the company, including the acquisition of Louisville Perfusion Services and Ohio Valley Perfusion Associates, and their

Tone
Positive 77/100
Event
Deals and strategy
Published
22 Jun 2026 01:26
Source
www.marketscreener.com
TradingKey Direct company coverage

Strata Critical Medical Ord Shs Class A (SRTA) Earnings Forecast: Future EPS & Revenue Growth Estimates

Strata Critical Medical Ord Shs Class A (SRTA) has a target price of USD 9.62, with analysts forecasting a buy trend based on 4 ratings. The expected revenue for the next quarter is $67.05 million, and the EPS forecast for the upcoming quarter is $0.01, following a previous quart

Tone
Positive 72/100
Event
Earnings
Published
18 Jun 2026 03:39
Source
TradingKey
TradingKey Direct company coverage

Strata Critical Medical Ord Shs Class A (SRTA) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Strata Critical Medical Ord Shs Class A (SRTA), detailing its market capitalization, P/E TTM ratio, and current stock price. It notes that key valuation metrics such as P/E, P/B, P/S, and P/CF have not yet been disclosed by the compa

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 22:39
Source
TradingKey
Market source Direct company coverage

Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?

Strata Critical Medical, Inc. (SRTA) saw an 8.5% surge in its stock price, closing at $5.89, likely driven by investor optimism following its acquisition of Louisville Perfusion Services, Inc. This all-cash transaction involves an upfront consideration of $16 million and up to $4

Tone
Positive 66/100
Event
Deals and strategy
Published
16 Jun 2026 08:14
Source
Market source
Investing.com Direct company coverage

Strata critical medical co-CEO disposes of $185,908 in stock

William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc. (NASDAQ:SRTA), disposed of 31,671 shares valued at $185,908 on June 8, 2026. This transaction involved stock withheld to cover tax obligations related to restricted stock units. Despite a challenging week for the

Tone
Neutral 50/100
Event
Market update
Published
11 Jun 2026 10:09
Source
Investing.com
Stock Titan Direct company coverage

[Form 4] Strata Critical Medical, Inc. Insider Trading Activity

Strata Critical Medical's Chief Accounting Officer, Cohen Amir, reported an open-market sale of 4,655 shares of Class A common stock at $5.87 per share on June 8, 2026. After this transaction, Amir directly holds 146,608 shares. The sale, valued at $27,325, is detailed in a Form

Tone
Negative 40/100
Event
Market update
Published
10 Jun 2026 19:40
Source
Stock Titan
Finviz Direct company coverage

SRTA - Strata Critical Medical Inc Stock Price and Quote

This article provides a detailed stock price quote and company information for Strata Critical Medical Inc (SRTA). It includes financial data, performance metrics, analyst ratings with target prices, recent news releases about acquisitions and earnings, and insider transaction de

Tone
Neutral 50/100
Event
Deals and strategy
Published
05 Jun 2026 08:09
Source
Finviz
GlobeNewswire Direct company coverage

Strata Acquires Louisville Perfusion Services

Strata Critical Medical, Inc. has acquired Louisville Perfusion Services (LPS), a regional provider of perfusion and blood management services in Kentucky. This all-cash acquisition, valued at approximately $16 million upfront and up to $4 million in additional consideration, is

Tone
Positive 74/100
Event
Deals and strategy
Published
03 Jun 2026 15:13
Source
GlobeNewswire
Stock Titan Direct company coverage

Heart surgery support firm Strata spends $16M on Kentucky perfusion group

Strata Critical Medical (Nasdaq: SRTA) has acquired Louisville Perfusion Services (LPS) for an upfront cash payment of approximately $16 million, with an additional earn-out potential of up to $4 million. This acquisition is set to expand Strata's cardiac perfusion platform, enha

Tone
Positive 67/100
Event
Deals and strategy
Published
31 May 2026 17:10
Source
Stock Titan
Stock Titan Direct company coverage

Strata Critical (SRTA) CAO Cohen sells 50,875 shares under 10b5-1 plan

Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc. (SRTA), sold a total of 50,875 shares of Class A common stock in open-market transactions on May 21 and May 22, 2026. These sales, totaling approximately $299,435, were conducted under a pre-arranged Rule 10b5-

Tone
Negative 30/100
Event
Market update
Published
27 May 2026 02:40
Source
Stock Titan
TradingView Direct company coverage

Number of shareholders of Strata Critical Medical, Inc. – NASDAQ:SRTA

This article provides details on how to find information about the number of shareholders for Strata Critical Medical, Inc. (NASDAQ: SRTA) on TradingView. It outlines the navigation path on the TradingView platform to access financial data for the company. The content also lists

Tone
Neutral 50/100
Event
Market update
Published
17 May 2026 11:09
Source
TradingView
Stock Titan Direct company coverage

1.58M Strata Critical (SRTA) warrants expire worthless

Strata Critical Medical, Inc. (SRTA) reported that 1.58 million warrants owned by Velibor Krstic, a ten percent owner, expired worthless on May 7, 2026. These warrants had an exercise price of $11.50 per share and were issued under a Warrant Agreement dated September 12, 2019. Fo

Tone
Negative 33/100
Event
Market update
Published
08 May 2026 19:39
Source
Stock Titan
Sahm Direct company coverage

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical, Inc. (Nasdaq: SRTA) announced the expiration of both its Public Warrants (Nasdaq: SRTAW) and Private Placement Warrants on May 7, 2026, at 5:00 p.m. Eastern Time. The company is a time-critical logistics and medical services provider for the U.S. healthca

Tone
Neutral 50/100
Event
Market update
Published
08 May 2026 08:40
Source
Sahm
Sahm Direct company coverage

Strata Critical Medical Q1 2026 Earnings Call: Complete Transcript

Strata Critical Medical reported an 87% year-over-year revenue increase in Q1 2026, driven by 32% organic growth in logistics and a significant contribution from its new clinical business. The company also announced the acquisition of Ohio Valley Perfusion Associates, aligning wi

Tone
Positive 82/100
Event
Deals and strategy
Published
08 May 2026 07:39
Source
Sahm
TradingView Direct company coverage

Strata Critical Medical, Inc. 1Q 2026: Revenue $67.38M, EPS $0.03— 10-Q Summary

Strata Critical Medical, Inc. (SRTA) reported significant growth in its first-quarter 2026 results, with revenue increasing by 87.4% year-over-year to $67.4 million and achieving profitability with a diluted EPS of $0.03. This improvement was driven by expansion in its Logistics

Tone
Neutral 50/100
Event
Earnings
Published
07 May 2026 07:39
Source
TradingView
Stock Titan Direct company coverage

Strata Critical Medical (NASDAQ: BLDE) nearly doubles revenue and posts Q1 profit

Strata Critical Medical (NASDAQ: BLDE) reported a significant financial improvement in Q1 2026, nearly doubling its revenue to $67.4 million and achieving a net income of $2.2 million, a reversal from a $3.5 million loss in the prior year. This growth was fueled by a 32.4% increa

Tone
Positive 70/100
Event
Earnings
Published
06 May 2026 15:39
Source
Stock Titan